AR057961A1 - Derivados de pirrolopirimidinas con actividad inhibitoria de receptor de tirosina quinasa. composiciones farmaceuticas. - Google Patents
Derivados de pirrolopirimidinas con actividad inhibitoria de receptor de tirosina quinasa. composiciones farmaceuticas.Info
- Publication number
- AR057961A1 AR057961A1 ARP060105330A ARP060105330A AR057961A1 AR 057961 A1 AR057961 A1 AR 057961A1 AR P060105330 A ARP060105330 A AR P060105330A AR P060105330 A ARP060105330 A AR P060105330A AR 057961 A1 AR057961 A1 AR 057961A1
- Authority
- AR
- Argentina
- Prior art keywords
- atom
- alkyl group
- pharmaceutical compositions
- thirosine
- pirrolopirimidinas
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000004429 atom Chemical group 0.000 abstract 3
- 125000005843 halogen group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- -1 3-chlorophenoxy Chemical group 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004528 pyrimidin-5-yl group Chemical group N1=CN=CC(=C1)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
El compuesto de la presente tiene una accion inhibidora de la tirosina quinasa superior. Composiciones farmacéuticas que los comprenden. Reivindicacion 1: Un compuesto caracterizado por la formula (1) en donde R1a es un átomo de H; R2a es un grupo alquilo C1-6 sustituido con un grupo representado por alquilo C1-4 opcionalmente halogenado con -NR6a-CO-(CH2)n-SO2- en donde n es un numero entero de 1 a 4, R6a es un átomo de H o un grupo alquilo C1-4, y -(CH2)n-está opcionalmente sustituido con alquilo C1-4; R3a es un átomo de H o un grupo alquilo C1-6; R4a es un átomo de halogeno o un grupo alquilo C1-6; R5a es un átomo de halogeno o un grupo alquilo C1-6; y Xa es un átomo de H o un átomo de halogeno, o una de sus sales, con la condicion de que se excluya N-[2-(4-{[3-cloro-4-(3-clorofenoxi)fenil]amino}-5H-pirrolo[3,2-d]pirimidin-5-il)etil]-2-(metilsulfonil)acetamida.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005349858 | 2005-12-02 | ||
| JP2006060648 | 2006-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR057961A1 true AR057961A1 (es) | 2007-12-26 |
Family
ID=37897379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060105330A AR057961A1 (es) | 2005-12-02 | 2006-12-01 | Derivados de pirrolopirimidinas con actividad inhibitoria de receptor de tirosina quinasa. composiciones farmaceuticas. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100216788A1 (es) |
| EP (1) | EP1957495A1 (es) |
| JP (1) | JP2009517333A (es) |
| KR (1) | KR20080084823A (es) |
| AR (1) | AR057961A1 (es) |
| AU (1) | AU2006319787A1 (es) |
| BR (1) | BRPI0619911A2 (es) |
| CA (1) | CA2631066A1 (es) |
| CR (1) | CR10057A (es) |
| MA (1) | MA30046B1 (es) |
| NO (1) | NO20082870L (es) |
| PE (1) | PE20071089A1 (es) |
| RU (1) | RU2008126949A (es) |
| TW (1) | TW200730527A (es) |
| WO (1) | WO2007064045A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20105024B (en) * | 2004-06-02 | 2010-06-25 | Takeda Pharmaceuticals Co | Fused heterocyclic compound |
| JPWO2008072634A1 (ja) * | 2006-12-12 | 2010-04-02 | 武田薬品工業株式会社 | 縮合複素環化合物 |
| US7825127B2 (en) | 2006-12-28 | 2010-11-02 | Takeda Pharmaceutical Company, Limited | Method for treating cancer |
| CA2691251A1 (en) | 2007-06-19 | 2008-12-24 | Yoshikazu Ohta | Preventive/remedy for cancer |
| WO2009110416A1 (ja) * | 2008-03-03 | 2009-09-11 | 武田薬品工業株式会社 | 併用剤 |
| AR070874A1 (es) * | 2008-03-12 | 2010-05-12 | Takeda Pharmaceutical | Compuesto heterociclico fusionado, una composicion farmaceutica que lo comprende y su uso en el tratamiento del cancer. |
| JP2014520151A (ja) | 2011-06-20 | 2014-08-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 蠕虫感染を処置するためのヘテロ環式化合物 |
| WO2013159095A1 (en) * | 2012-04-20 | 2013-10-24 | Anderson Gaweco | Ror modulators and their uses |
| SI3049417T1 (sl) * | 2013-07-31 | 2019-03-29 | Merck Patent Gmbh | Piridini, pirimidini in pirazini kot inhibitorji BTK in njihove uporabe |
| GB201520499D0 (en) * | 2015-11-20 | 2016-01-06 | Medical Res Council Technology | Compounds |
| AU2022257621A1 (en) | 2021-04-13 | 2023-11-23 | Nuvalent, Inc. | Amino-substituted heterocycles for treating cancers with egfr mutations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| GEP20105024B (en) * | 2004-06-02 | 2010-06-25 | Takeda Pharmaceuticals Co | Fused heterocyclic compound |
| KR101257343B1 (ko) * | 2004-07-30 | 2013-04-23 | 메틸진 인코포레이티드 | Ｖｅｇｆ 수용체 및 ｈｇｆ 수용체 신호전달 억제제 |
| TW200740820A (en) * | 2005-07-05 | 2007-11-01 | Takeda Pharmaceuticals Co | Fused heterocyclic derivatives and use thereof |
-
2006
- 2006-11-30 TW TW095144339A patent/TW200730527A/zh unknown
- 2006-12-01 KR KR1020087016193A patent/KR20080084823A/ko not_active Application Discontinuation
- 2006-12-01 AR ARP060105330A patent/AR057961A1/es unknown
- 2006-12-01 AU AU2006319787A patent/AU2006319787A1/en not_active Abandoned
- 2006-12-01 BR BRPI0619911A patent/BRPI0619911A2/pt not_active IP Right Cessation
- 2006-12-01 RU RU2008126949/04A patent/RU2008126949A/ru not_active Application Discontinuation
- 2006-12-01 WO PCT/JP2006/324499 patent/WO2007064045A1/en active Application Filing
- 2006-12-01 EP EP06834254A patent/EP1957495A1/en not_active Withdrawn
- 2006-12-01 CA CA002631066A patent/CA2631066A1/en not_active Abandoned
- 2006-12-01 US US12/095,543 patent/US20100216788A1/en not_active Abandoned
- 2006-12-01 JP JP2008520459A patent/JP2009517333A/ja not_active Withdrawn
- 2006-12-01 PE PE2006001541A patent/PE20071089A1/es not_active Application Discontinuation
-
2008
- 2008-06-09 CR CR10057A patent/CR10057A/es not_active Application Discontinuation
- 2008-06-11 MA MA31024A patent/MA30046B1/fr unknown
- 2008-06-24 NO NO20082870A patent/NO20082870L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CR10057A (es) | 2008-07-29 |
| JP2009517333A (ja) | 2009-04-30 |
| AU2006319787A1 (en) | 2007-06-07 |
| NO20082870L (no) | 2008-09-01 |
| EP1957495A1 (en) | 2008-08-20 |
| KR20080084823A (ko) | 2008-09-19 |
| TW200730527A (en) | 2007-08-16 |
| BRPI0619911A2 (pt) | 2016-08-30 |
| CA2631066A1 (en) | 2007-06-07 |
| WO2007064045A1 (en) | 2007-06-07 |
| RU2008126949A (ru) | 2010-01-10 |
| MA30046B1 (fr) | 2008-12-01 |
| US20100216788A1 (en) | 2010-08-26 |
| PE20071089A1 (es) | 2007-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR057961A1 (es) | Derivados de pirrolopirimidinas con actividad inhibitoria de receptor de tirosina quinasa. composiciones farmaceuticas. | |
| RS51548B (en) | PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS | |
| CO6220855A2 (es) | Compuesto a base de 54 -fenil-6-(2,2,2-trifluoro-1-feniletoxi)pirimidina y metodos para su empleo | |
| DK1483265T3 (da) | Purinderivater som kinaseinhibitorer | |
| AR055959A1 (es) | Derivados espiro para la modulacion de actividad de crth2 | |
| NO20082447L (no) | Biaryl-meta-pyrimidininhibitorer av kinaser, eller farmasøytisk akseptable salter, hydrater, solvater, krystallformer, N-oksider og individuelle diastereomerer derav, farmasøytisk sammensetning derav, samt anvendelser derav for behandling av forstyrrelser. | |
| AR055613A1 (es) | Formas cristalinas delta y epsilon de mesilato de imatinib | |
| AR092289A1 (es) | Derivados de aminoquinazolina y sus sales y metodos de uso | |
| CR8505A (es) | Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad | |
| AR055071A1 (es) | Derivados de pirrolo (3,2 - b) pirimidina. composiciones farmaceuticas. | |
| AR031627A1 (es) | Activadores heteroaromaticos fusionados de la glucoquinasa | |
| CO5590927A2 (es) | Derivados de 02-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas su procedimiento de sistesis y composiciones farmaceuticas que los contienen | |
| DK1817301T3 (da) | Forstærkere af glutamat-receptorer | |
| NO20060702L (no) | Aminokinolinderivater og deres anvendelse som adenosin A3 ligander | |
| CO5590895A2 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos | |
| NO20033145L (no) | Purinderivater som purinergiske reseptorantagonister | |
| ES2655091T3 (es) | Derivados del ácido pirrolidíncarboxílico como agonistas del receptor 43 acoplado a proteína G (GPR43), composición farmacéutica y métodos para su uso en el tratamiento de trastornos metabólicos | |
| DK1611144T3 (da) | Derivater af 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl-phosphonsyre og deres avendelse som n-methyl-D-aspartat (NMDA)-receptor-antagonister | |
| DE60336267D1 (de) | Uracilderivate mit herbizider wirkung | |
| NO20075734L (no) | Tiofenforbindelser og trombopoietin reseptoractivatorer | |
| AR060810A1 (es) | Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn | |
| ATE505462T1 (de) | Neue biologischaktive molekü le | |
| PE20021003A1 (es) | Fenil-heterociclil-eteres como inhibidores selectivos de la recaptacion de serotonina (ssri) | |
| NO20090332L (no) | 4-amino-3-arylamino-6-arylpyrazol[3,4-D]pyrimidinderivater, fremgangsmater for deres fremstilling og dere anvendelse som antivirale midler | |
| JOP20220084A1 (ar) | مشتقات 5-أوكسا- 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |